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www.bio-protocol.org/e2836 Vol 8, Iss 09, May 05, 2018 DOI:10.21769/BioProtoc.2836 Seglen et al., 1979) , or involved relatively high amounts of radioactivity (Mizushima et al., 2001; Fuertes et al., 2003a) , which is expensive. Recently, we have downscaled and simplified the LLPD protocol to the validated time-and cost-efficient version that we present here.
An overview of the method is shown in Figure 1 . To label proteins with radioactive valine, cells are seeded in 24-well plates in complete medium supplemented with 14 C valine. As proteins are synthesised, they incorporate amino acids, including the 14 C valine present in the medium, and therefore the amount of long-lived 14 C valine-labelled proteins increases with time ( Figure 1 , first part of the curve). Valine is an optimal amino acid to use in the LLPD method, since it is a poorly metabolised amino acid, is well tolerated at high doses, and does not influence autophagy or protein degradation rates . Moreover, free valine is readily exchanged over the plasma membrane (Seglen and Solheim, 1978) , enabling efficient wash-out of released 14 C valine. After 2-3 days of labelling, unincorporated 14 
C
valine is removed by a simple wash procedure, and the cells receive new medium supplemented with a high concentration of non-radioactive ('cold') valine ('chase medium'). The large surplus of cold valine prevents reincorporation of released 14 C valine. Thus, from this point on the presence of free 14 C valine is a result of endogenous protein degradation. After a chase period of 18 h, the free 14 C valine that has been produced by degradation of short-lived proteins (predominantly due to proteasomal degradation) is washed out. Next, a second chase period, which we call the 'sampling period', is initiated along with experimental treatments and proper controls. Generally, we use a sampling period of 2-6 h to monitor the degradation of long-lived proteins. At the end of the sampling period, trichloroacetic acid (TCA) is added to precipitate intact proteins. The TCA-soluble fraction of degraded proteins (containing free amino acids and small peptides) is separated from the TCA-insoluble fraction (containing intact proteins) by centrifugation, and the radioactivity in each fraction is measured by liquid scintillation counting. This allows calculation of the rate of long-lived protein degradation in the sampling period, expressed as the C valine by a washing step. Consequently, only the degradation of long-lived proteins is followed in the 2-6 h sampling period. Compared to cells kept in complete, nutrient-rich medium (red line), incubating cells with EBSS starvation medium or the mTOR-inhibitor Torin1 produces a very strong degradation of long-lived proteins in the sampling period, due to enhanced bulk autophagy (green line). Autophagic-lysosomal LLPD can be revealed by treatment with the lysosomal inhibitor Bafilomycin A1 (Baf) or RNAi-mediated silencing of key ATGs (siATGs) (yellow line), whereas the contribution to LLPD from the proteasome can be assessed by treatment with proteasomal inhibitors like MG132 (purple line). Blocking both autophagic-lysosomal and proteasomal activity simultaneously will abrogate both main sources of LLPD, thus resulting in minimal loss of 14 C-labelled intact protein (black line). Note that the rise and fall in the curves are schematic and purely intended for illustrative purposes-they are not intended to indicate exact details in the kinetics of long-lived protein labelling and/or degradation. See text for a more detailed description of each of the protocol steps and for representative examples of data.
Materials and Reagents
In the current protocol we use: 3. Seed cells in a 24-well plate in 0.5 ml CM supplemented with 14 C-valine to a final concentration 0.1 µCi/ml. Seed a cell number that will lead to the desired monolayer confluency at the time of 3. Aspirate the medium and add your treatments in 0.25 ml 37 °C CM-V or EBSS-V.
4. Incubate the cells for 2-6 h in a humidified incubator at 37 °C and 5% CO2.
D. Harvest

Day 1
1. Remove the plate with cells from the incubator and cool it on ice for ~2 min.
2. Add 50 µl ice-cold PBS/2%BSA per well.
Note: BSA is added as a protein carrier to facilitate protein precipitation with TCA.
3. Add 200 µl ice-cold 25% TCA per well to precipitate protein.
4. Place the plate on a shaker at 4 °C and let it shake over night at 600 rpm.
Note: Whereas overnight TCA precipitation is sufficient, the precipitation may be extended for several days without affecting the results.
Day 2
5. Transfer the precipitated protein (~500 µl) from each well to 1.5 ml microcentrifuge tubes. 7. After the centrifugation, place the tubes on ice.
8. Transfer the supernatant (~500 µl) from each tube into 6 ml scintillation vials.
9. Solubilise the pellet by adding 250 µl 0.2 M KOH per tube and rotating the tubes for at least 1 h at room temperature.
Note: It is not necessary to wash the pellet prior to solubilising it in KOH.
10. Solubilise remaining protein precipitate in the 24-well plate by adding 250 µl 0.2 M KOH per well.
11. Rotate on a shaker at 600 rpm for 1 h at room temperature.
12. Merge the solubilised protein from the respective wells and tubes (~500 µl) and transfer to 6 ml scintillation vials.
Fill each vial from
Steps D8 and D12 with 4 ml scintillation liquid. Cap the tubes, and vortex hard.
Note: The scintillation liquid is an organic and toxic substance. For your own protection, add scintillation liquid, cap tubes, and vortex in a flow-cabinet, wearing protective gloves and lab coat.
14. Measure the amount of radioactivity in all of the tubes by liquid scintillation counting (see Note 2 in the separate Notes section for comments on scintillation counting and the variability of assay measurements).
Data analysis
A. Representative examples of data
As detailed in the protocol above, we in general label proteins for 2-3 days followed by a chase for 18 h to enrich for radioactively labelled long-lived proteins. The chase can be reduced or extended to suit other experimental setups than shown here. It is, however, important to be aware that this will enrich for proteins with a different half-life, which in turn may alter the overall protein degradation rate during the sampling period, as well as the outcome of your experimental treatments (see further explanation in Note 3 in the Notes section). We therefore recommend keeping the labelling and chase periods as consistent as possible. As an example, decreasing the chase period from 18 h to 1 h increased the overall protein degradation rate from ≈ 1.05%/h to ≈ 1.3 %/h in LNCaP cells ( Figure   2A ). mTOR suppresses autophagy in a manner that is sensitive to the presence of amino acids and growth factors (Meijer et al., 2015) . Thus, upon removal of amino acids and serum from the medium, mTOR activity is inhibited, and autophagy is induced. Figure 2D shows the typical response of LNCaP cells to treatment with the mTOR-inhibitor Torin1 or acute amino acid-and serum-starvation; total LLPD is increased by about two-fold, in a manner that in both cases is strongly sensitive to Baf,
i.e., dependent on lysosomal activity. The increase in LLPD observed upon acute starvation differs from cell line to cell line. For example, the effect is weaker in VCaP and Huh7 cells compared to U2OS ( Figure 2E ) and LNCaP cells ( Figure 2D) . Importantly, the starvation-induced LLPD is sensitive to Baf in all cell lines, demonstrating that it mainly induces lysosomal LLPD. Of note, however, Baf does not completely abolish the effects of mTOR-inhibition or starvation ( Figures 2D-2E ), likely because these conditions slightly elevate proteasomal activity as well as autophagy 2. Liquid scintillation counters can be set to record counts either for a specific time period, or until a specific number of counts has been accumulated. The uncertainty in the measurements is inversely correlated with the total number of counts. We recommend setting up the counter to accumulate at least 10,000 counts, whereby the standard deviation will be ≤ 1.0%. Following the current protocol with 2-3 days labelling with 0.1 µCi/ml 14 C valine, these settings typically require less than a minute of counting for the TCA-insoluble fractions and a few minutes of counting for the TCA-soluble fractions. The background level is set during standard 14 C calibration, and is very low (≤ 22 CPM). In the standard measurement protocol, this background is automatically subtracted from each sample. There is therefore no need to include additional background sample measurements (which would require many hours of sampling time for accurate measurement). As a general note, we recommend contacting your local service engineer for maintenance, calibration, and service questions.
3. Different durations of the labelling, chase, and sampling periods than those presented here can be used. For example, some previous protocols used an 18-24 h labelling period, followed by a transfection, e.g., with the reverse siRNA transfection described here. Moreover, the longer the labelling period, the more long-lived proteins (which are slowly synthesized and slowly degraded)
will be labelled. It should be noted that in human fibroblasts, a pool of short-lived proteins that is predominantly degraded by the proteasome and not by macroautophagy has been described (Fuertes et al., 2003b) . This pool of proteins showed a half-life of ~1.1-1.3 h, and an ~8 h chase period was required to fully eliminate them (Fuertes et al., 2003b) . It was found that during 1-4 h of chase, 5-7.5% of the initial TCA-insoluble radioactivity of short-labelled proteins reflected the cellular release of non-degraded TCA-insoluble proteins to the medium. This release decreased to about 1/10th of the above values after 8 h of chase (Fuertes et al., 2003b) . In summary, we advise a chase period of > 8 h, to minimize the influence of degradation and/or secretion of short-lived proteins. To be on the safe side, we routinely use an 18 h chase period.
Such a long chase period has the additional advantage that when wishing to analyse effects of long-term experimental treatments on LLPD, the treatments can be initiated during the chase period (see Step B4b). Moreover, since the chase period is usually followed by a sampling period of 2-6 h, it is in relation to working hours more convenient with an 18 h chase period than an 8 h chase period. The sampling period can be longer than 6 h if desired, but if combining the assay with control treatments such as lysosomal and proteasomal inhibitors (as we recommend), it is advisable to keep the period shorter than 6 h to minimize secondary effects of the inhibitors.
If wishing to analyse effects of experimental treatments on LLPD after more than 18 h of treatment, one may either increase the duration of the chase period, or even start the treatments during the labelling period, as alternatives to increasing the duration of the sampling period.
Finally, the assay can also be done with shorter sampling periods than 2 h, but then great care must be taken to assure even time points for each experimental sample, and one may have to increase the amount of radioactive 14 C-valine to achieve a higher degree of labelling and thus obtain an adequate level of counts in the scintillation counter (see Note 2 above). 
